Galapagos Profit Margin 2013-2021 | GLPG
Current and historical gross margin, operating margin and net profit margin for Galapagos (GLPG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Galapagos net profit margin as of June 30, 2021 is -34.21%.
|Galapagos Annual Profit Margins
|Galapagos Quarterly Profit Margins
||Medical - Biomedical and Genetics
Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.